Alumis (ALMS) Capital Expenditures (2023 - 2025)

Alumis (ALMS) reported Capital Expenditures of $616000.0 for Q2 2025, up 42.59% year-over-year from $432000.0 in Q2 2024, and up 1564.86% quarter-over-quarter from $37000.0 in Q1 2025.

Alumis (ALMS) Capital Expenditures (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Capital Expenditures data on file, last reported at $616000.0 in Q2 2025.

  • Capital Expenditures for Q2 2025 came in at $616000.0, up 42.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $653000.0 (down 62.3% YoY), and the FY2025 annual result was $653000.0, down 62.3% from the prior year.
  • Capital Expenditures rose to $616000.0 in Q2 2025 per ALMS's latest filing, from $37000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.2 million in Q3 2023 and troughed at $37000.0 in Q1 2025.
  • A 3-year average of $720500.0 and a median of $524000.0 in 2024 frame the typical range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 42.59% in 2025 and fell as far as 76.13% in 2025.
  • A 3-year view of Capital Expenditures shows it stood at $1.2 million in 2023, then slumped by 69.75% to $366000.0 in 2024, then surged by 68.31% to $616000.0 in 2025.
  • Business Quant data shows ALMS's Capital Expenditures at $616000.0 in Q2 2025, $37000.0 in Q1 2025, and $366000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Alumis 1.99 Bn 1.90 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 616,000.00
Jun 30, 2025 616,000.00
Mar 31, 2025 37,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 366,000.00
Dec 31, 2024 366,000.00
Sep 30, 2024 779,000.00
Sep 30, 2024 779,000.00
Jun 30, 2024 432,000.00
Jun 30, 2024 432,000.00
Mar 31, 2024 155,000.00
Mar 31, 2024 155,000.00
Dec 31, 2023 1.21 Mn
Dec 31, 2023 1.21 Mn
Sep 30, 2023 2.17 Mn
Sep 30, 2023 2.17 Mn